Clinical outcomes and safety profile of Tenecteplase in wake-up stroke.

Hassan Khan AhmedNicola LogalloLars ThomassenVojtech NovotnySara M MathisenMartin W Kurz

Published in: Acta neurologica Scandinavica (2020)

In WUPS patients treated in NOR-TEST, there was no difference in clinical outcomes at 90 days and no ICH events or deaths were observed in either alteplase- or tenecteplase-treated patients. Clinical Trial Registration-URL: https://www.clinicaltrials.gov. Unique identifier: NCT01949948.

Keyphrases

clinical trial
end stage renal disease
newly diagnosed
ejection fraction
atrial fibrillation
peritoneal dialysis
prognostic factors
randomized controlled trial
phase ii